October 22, 2019  BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729,PEA-PME savings plans eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, announces that its JAZZ Lock® technology, which is an integral part of its JAZZ™ solutions platform, has been granted a patent in Japan. Implanet …